MIRD pamphlet no. 26: joint EANM/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy

M Ljungberg, A Celler, MW Konijnenberg… - Journal of nuclear …, 2016 - Soc Nuclear Med
The accuracy of absorbed dose calculations in personalized internal radionuclide therapy is
directly related to the accuracy of the activity (or activity concentration) estimates obtained at …

Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study

A Chicheportiche, M Sason, J Godefroy, Y Krausz… - EJNMMI physics, 2021 - Springer
Background Following each cycle of peptide receptor radionuclide therapy (PRRT),
absorbed doses by tumors and normal organs are typically calculated from three …

Status of the decay data for medical radionuclides: existing and potential diagnostic γ emitters, diagnostic β+ emitters and therapeutic radioisotopes

AL Nichols - Radiochimica Acta, 2022 - degruyter.com
Recommended half-lives and specific well-defined emission energies and absolute
emission probabilities are important input parameters that should be well-defined to assist in …

Activity determination and nuclear decay data of 177Lu

K Kossert, OJ Nähle, O Ott, R Dersch - Applied Radiation and Isotopes, 2012 - Elsevier
The activity concentration of a 177Lu solution was measured within the scope of the
international comparison CCRI (II)-K2. Lu-177, starting in 2009. At PTB, the solution was …

Recommended standards for gamma ray intensities

MM Bé, VP Chechev - Nuclear Instruments and Methods in Physics …, 2013 - Elsevier
Gamma ray data are used in more and more areas of application, and so over the years the
demand for recommended gamma ray energies and intensities has increased. This paper …

[HTML][HTML] A simple method to shorten the apparent dead time in the dosimetry of Lu-177 for targeted radionuclide therapy using a gamma camera

K Nakanishi, N Fujita, S Abe, R Nishii, K Kato - Physica Medica, 2024 - Elsevier
Background The dead-time loss reportedly degrades the accuracy of dosimetry using a
gamma camera for targeted radionuclide therapy with Lu-177; therefore, the dead-time loss …

A Monte Carlo study comparing dead-time losses of a gamma camera between tungsten functional paper and lead sheet for dosimetry in targeted radionuclide …

K Nakanishi, N Fujita, H Iwanaga, Y Asano… - Annals of Nuclear …, 2024 - Springer
Objective Dead-time loss is reported to be non-negligible for some patients with a high
tumor burden in Lu-177 radionuclide therapy, even if the administered activity is 7.4 GBq …

177Lu: DDEP Evaluation of the decay scheme for an emerging radiopharmaceutical

MA Kellett - Applied Radiation and Isotopes, 2016 - Elsevier
A new decay scheme evaluation using the DDEP methodology for 177 Lu is presented.
Recently measured half-life measurements have been incorporated, as well as newly …

In vitro evaluation of targeted antisense 177Lu radiotherapy

ER Balkin, F Jia, WH Miller, MR Lewis - Anticancer research, 2011 - ar.iiarjournals.org
Background: The BCL2 proto-oncogene in non-Hodgkin's lymphoma is a dominant inhibitor
of apoptosis. The goal of this work was to develop a 177Lu-labeled anti-BCL2-peptide …

Design and development of a mini-orange magnetic spectrometer with multichannel facility for conversion electron spectroscopy

K Venkataramaniah, M Sainath, KV Sai… - Journal of Nuclear …, 2020 - jnp.chitkara.edu.in
Background: Conventional magnetic spectrometers used for conversion electron detection
are very cumbersome, require strong magnetic fields and the spectra have to be scanned …